Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (25)

2024

  1. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  2. Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 6, pp. 3115

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Effect of cilastatin on cisplatin-induced nephrotoxicity in patients undergoing hyperthermic intraperitoneal chemotherapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-17

2020

  1. Nephroprotective effect of cilastatin against gentamicin-induced renal injury in vitro and in vivo without altering its bactericidal efficiency

    Antioxidants, Vol. 9, Núm. 9, pp. 1-25

2018

  1. Efficacy, biodistribution, and nephrotoxicity of experimental amphotericin B-deoxycholate formulations for pulmonary aspergillosis

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 7

2017

  1. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 10, pp. 1645-1655

2016

  1. Beneficial effect of short pretransplant period of hypothermic pulsatile perfusion of the warm-ischemic kidney after cold storage: Experimental study

    BioMed Research International, Vol. 2016

  2. Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: Comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin

    Analytical and Bioanalytical Chemistry, Vol. 408, Núm. 9, pp. 2309-2318

2015

  1. Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity

    BioMed Research International, Vol. 2015

2013

  1. The authors reply

    Kidney International

2012

  1. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

    Kidney International, Vol. 82, Núm. 6, pp. 652-663

  2. LA-ICP-MS and nHPLC-ESI-LTQ-FT-MS/MS for the analysis of cisplatin-protein complexes separated by two dimensional gel electrophoresis in biological samples

    Journal of Analytical Atomic Spectrometry, Vol. 27, Núm. 9, pp. 1474-1483

2011

  1. Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD

    Thorax, Vol. 66, Núm. 2, pp. 121-127

  2. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies

    Analytical Chemistry, Vol. 83, Núm. 20, pp. 7933-7940

2010

  1. Cilastatin attenuates cisplatin-induced proximal tubular cell damage

    Journal of Pharmacology and Experimental Therapeutics, Vol. 334, Núm. 2, pp. 419-429

2009

  1. Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease

    American Journal of Respiratory Cell and Molecular Biology, Vol. 40, Núm. 6, pp. 746-750

  2. Pharmacoproteomics in cardiac hypertrophy and atherosclerosis

    Cardiovascular and Hematological Disorders - Drug Targets, Vol. 9, Núm. 2, pp. 141-148

  3. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies

    Hypertension Research, Vol. 32, Núm. 5, pp. 347-357

2008

  1. Papel del túbulo en la vasoconstricción renal inducida por ciclosporina

    Actas Urologicas Espanolas, Vol. 32, Núm. 1, pp. 128-139